DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dresser, M. J.
Right arrow Articles by Giacomini, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dresser, M. J.
Right arrow Articles by Giacomini, K. M.

Vol. 28, Issue 9, 1135-1140, September 2000

ACCELERATED COMMUNICATION
Electrophysiological Analysis of the Substrate Selectivity of a Sodium-Coupled Nucleoside Transporter (rCNT1) Expressed in Xenopus laevis Oocytes

Mark J. Dresser, Karin M. Gerstin, Andrew T. Gray, Donald D. F. Loo, and Kathleen M. Giacomini

Departments of Biopharmaceutical Sciences (M.J.D., K.M.G., K.M.G.) and Anesthesia (A.T.G.), University of California-San Francisco, Schools of Pharmacy and Medicine, San Francisco, California; and Department of Physiology (D.D.F.L.), UCLA School of Medicine, Los Angeles, California

Nucleoside transporters that mediate cellular uptake of therapeutic nucleoside analogs are major determinants of the pharmacokinetic properties of these compounds. Understanding the substrate selectivity of these transporters is critical in the development of therapeutic nucleoside analogs with optimal pharmacokinetic properties, including high oral bioavailability and tissue-specific distribution. In general, substrate selectivity of nucleoside transporters has been evaluated indirectly by inhibition studies. The purpose of this study was to directly measure the transport of nucleoside analogs by the sodium-coupled pyrimidine-selective transporter rCNT1 using electrophysiology methods. We used a two-electrode voltage clamp assay to investigate the substrate selectivity of rCNT1; 19 structurally diverse nucleosides and nucleoside analogs were studied. Uridine-induced currents in voltage-clamped oocytes expressing rCNT1 were sodium-, voltage-, and concentration-dependent (K0.5 = 21 µM), and were blocked by adenosine. Uridine-induced currents increased ~5-fold upon hyperpolarization of membrane potential from -10 to -150 mV. Uridine, thymidine, and cytidine induced currents in rCNT1-expressing oocytes, whereas guanosine, inosine, and adenosine did not. Uridine, deoxyuridine, and cytidine analogs with modifications at the 3-, 4-, or 5-position were found to be substrates of rCNT1, whereas uridine and cytidine analogs modified at the 6-position were not. In addition, it was found that the 5'-hydroxyl group of the sugar is not required for transport by rCNT1. These results enhance our understanding of the structural basis for substrate selectivity of nucleoside transporters and should prove useful in the development of therapeutic nucleoside analogs.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Physiol.Home page
K. M. Smith, A. M. L. Ng, S. Y. M. Yao, K. A. Labedz, E. E. Knaus, L. I. Wiebe, C. E. Cass, S. A. Baldwin, X.-Z. Chen, E. Karpinski, et al.
Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes
J. Physiol., August 1, 2004; 558(3): 807 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. M. Larrayoz, F. J. Casado, M. Pastor-Anglada, and M. P. Lostao
Electrophysiological Characterization of the Human Na+/Nucleoside Cotransporter 1 (hCNT1) and Role of Adenosine on hCNT1 Function
J. Biol. Chem., March 5, 2004; 279(10): 8999 - 9007.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. M. Gerstin, M. J. Dresser, and K. M. Giacomini
Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F344 - F349.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. F. Mata, J. M. Garcia-Manteiga, M. P. Lostao, S. Fernandez-Veledo, E. Guillen-Gomez, I. M. Larrayoz, J. Lloberas, F. J. Casado, and M. Pastor-Anglada
Role of the Human Concentrative Nucleoside Transporter (hCNT1) In the Cytotoxic Action of 5[Prime]-Deoxy-5-fluorouridine, an Active Intermediate Metabolite of Capecitabine, a Novel Oral Anticancer Drug
Mol. Pharmacol., June 1, 2001; 59(6): 1542 - 1548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Soler, R. Valdes, J. Garcia-Manteiga, J. Xaus, M. Comalada, F. J. Casado, M. Modolell, B. Nicholson, C. MacLeod, A. Felipe, et al.
Lipopolysaccharide-induced Apoptosis of Macrophages Determines the Up-regulation of Concentrative Nucleoside Transporters Cnt1 and Cnt2 through Tumor Necrosis Factor-alpha -dependent and -independent Mechanisms
J. Biol. Chem., August 3, 2001; 276(32): 30043 - 30049.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.